An investigational drug combination offers renewed hope of a cure for chronic hepatitis C (HCV) patients who have tried and failed therapy with the new direct-acting antiviral agents, a researcher said here. Read the full story at MedPage Today
Medical researchers have claimed that an investigational combination of drugs can effectively treat chronic hepatitis C cases. Using the direct-acting antiviral agents used in the experimental treatment, the research team reported over 90 percent success rate for HCV patients. Read the full story at Maine News Online
One of Dr. Thomas Oates’ many responsibilities is instructing and guiding dental residents. A few years ago, one of his students approached him with a question he couldn’t answer: What should she do for a patient with diabetes who desperately needed an implant to replace a missing tooth?